Clinical investigators as critical determinants in pharmaceutical innovation

被引：30

作者：

Flowers, CR ^{[1
]}

Melmon, KL ^{[1
]}

机构：

[1] STANFORD UNIV, MED CTR, SCH MED, DIV CLIN PHARMACOL, STANFORD, CA 94305 USA

来源：

NATURE MEDICINE | 1997年 / 3卷 / 02期

关键词：

D O I：

10.1038/nm0297-136

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：136 / 143

页数：8

共 82 条

[1]

Allen T.J.J., 1984, Managing the Flow of Technology: Technology Transfer and the Dissemination of Technological Information within the R&D Organization, Vfirst

[2]

[Anonymous], 1993, COMPANION ENCY HIST

[3]

[Anonymous], MANAGING FLOW SCI TE

[4] AN INDUSTRIAL-APPROACH TO DRUG DISCOVERY - A PHARMACOLOGISTS EYEVIEW [J].

ARMSTRONG, JM ;

HICKS, PE .

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, 19 (01) :51-56

[5]

BURCHENAL JH, 1949, CANCER, V2, P119, DOI 10.1002/1097-0142(194901)2:1<119::AID-CNCR2820020111>3.0.CO

[6]

2-U

[7]

BURCHENAL JH, 1951, CANCER-AM CANCER SOC, V4, P549, DOI 10.1002/1097-0142(195105)4:3<549::AID-CNCR2820040308>3.0.CO

[8]

2-J

[9]

BURCHENAL JH, 1949, CANCER, V2, P113, DOI 10.1002/1097-0142(194901)2:1<113::AID-CNCR2820020110>3.0.CO

[10]

2-E

← 1 2 3 4 5 6 7 8 9 →